{
    "relation": [
        [
            "id",
            "1",
            "2",
            "3",
            "4",
            "5",
            "6",
            "7",
            "8",
            "9",
            "10",
            "11",
            "12",
            "13",
            "14",
            "15",
            "16",
            "17",
            "18",
            "19",
            "20",
            "21",
            "22",
            "23",
            "24",
            "25",
            "26",
            "27",
            "28"
        ],
        [
            "Super pathways (with members indented)",
            "NF-KappaB Family Pathway51 Show member pathways NF-KappaB (p50-p65) Pathway51",
            "Pathways in cancer29",
            "RhoGDI Pathway51 Show member pathways Fc-GammaR-Mediated Phagocytosis in Macrophages51",
            "Glioma29 Show member pathways Melanoma29 Non-small cell lung cancer29 Bladder cancer29 Prostate cancer29 Signaling Pathways in Glioblastoma36",
            "Neural Crest Differentiation36",
            "Angiogenesis4",
            "Signaling by FGFR1 mutants53 Show member pathways Signaling by FGFR1 fusion mutants53 Signaling by FGFR mutants53",
            "MAPK signaling pathway29 Show member pathways MAPK signaling pathway36",
            "Sorafenib Pharmacodynamics49 Show member pathways VEGF Pathway59 Vemurafenib Pathway, Pharmacodynamics49",
            "PI3K-Akt signaling pathway29",
            "p70S6K Signaling51 Show member pathways Renin-Angiotensin Pathway51 mTOR Pathway51",
            "Actin Nucleation by ARP-WASP Complex51 Show member pathways CDC42 Pathway51 RhoA Pathway51 Actin Nucleation and Branching51",
            "NFAT and Cardiac Hypertrophy51 Show member pathways Signaling Involved in Cardiac Hypertrophy51 IGF1R Signaling51",
            "ErbB4 Pathway51 Show member pathways UVC-Induced MAPK Signaling51 FGF Pathway51 LPS Stimulated MAPK Signaling51 Growth Hormone Signaling51 HMGB1 Pathway51 PACAP Signaling51 IL-4 Pathway51 Prolactin Signaling51 Thrombopoietin Pathway51 ErbB2-ErbB3 Heterodimers51 IL-2 Pathway51 PI3K Signaling in B-Lymphocyte51 TREM1 Pathway51 ErbB Family Pathway51",
            "Signaling by FGFR53 Show member pathways Signaling by constitutively active EGFR53 Signaling by EGFR53 DAP12 interactions53 DAP12 signaling53 Signaling by ERBB253 Signaling by FGFR in disease53 Signaling by PDGF53 Downstream signaling of activated FGFR53 Signaling by EGFR in Cancer53 Signalling by NGF53 Downstream signal transduction53 Downregulation of ERBB2-ERBB3 signaling53 NGF signalling via TRKA from the plasma membrane53",
            "PI-3K cascade53 Show member pathways Downregulation of ERBB4 signaling53 AKT phosphorylates targets in the nucleus53 Signaling by SCF-KIT53 PI3K events in ERBB2 signaling53 Fc epsilon receptor (FCERI) signaling53 PI3K events in ERBB4 signaling53 Signaling by ERBB453 GAB1 signalosome53 Negative regulation of the PI3K/AKT network53 Role of LAT2/NTAL/LAB on calcium mobilization53 PIP3 activates AKT signaling53 Regulation of KIT signaling53 AKT phosphorylates targets in the cytosol53 AKT-mediated inactivation of FOXO1A53 PI3K/AKT Signaling in Cancer53 Constitutive PI3K/AKT Signaling in Cancer53 PI3K/AKT activation53",
            "Ras signaling pathway29 Show member pathways Rap1 signaling pathway29",
            "Endocytosis29",
            "Tyrosine Kinases / Adaptors4",
            "Akt Signaling Pathway52",
            "VEGF Signaling Pathway49 Show member pathways VEGF Signaling54",
            "FGFR ligand binding and activation53 Show member pathways FGFR1c and Klotho ligand binding and activation53 Signaling by FGFR2 amplification mutants53 Klotho-mediated ligand binding53 FGFR2 ligand binding and activation53 Negative regulation of FGFR signaling53 FRS2-mediated cascade53 Signaling by FGFR1 amplification mutants53 FGFR1b ligand binding and activation53 SHC-mediated cascade53 FGFR4 ligand binding and activation53 betaKlotho-mediated ligand binding53 Signaling by FGFR2 mutants53 Signaling by FGFR4 mutants53 Development FGF family signaling58 FGFR1 ligand binding and activation53 Spry regulation of FGF signaling53 FGFR2c ligand binding and activation53 FGFR2b ligand binding and activation53 Activated point mutants of FGFR253",
            "Insulin receptor signalling cascade53 Show member pathways mTORC1-mediated signalling53 PKB-mediated events53 IRS-related events53 Inhibition of TSC complex formation by PKB53 IRS-mediated signalling53 IRS-related events triggered by IGF1R53 PDE3B signalling53 SHC-mediated signalling53 IRS activation53 Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)53 Energy dependent regulation of mTOR by LKB1-AMPK53 S6K1-mediated signalling53 Release of eIF4E53 IGF1R signaling cascade53 Regulation of Rheb GTPase activity by AMPK53 Signaling by Insulin receptor53 SHC-related events53 SOS-mediated signalling53 S6K1 signalling53 TOR signaling36 PI3K Cascade53 Regulation of AMPK activity via LKB153 mTOR signalling53 SHC activation53 SHC-related events triggered by IGF1R53 Signal attenuation53",
            "Apoptosis Pathway59 Show member pathways Akt Pathway59 NF-kappaB Pathway59",
            "Regulation of Actin Cytoskeleton36 Show member pathways Regulation of actin cytoskeleton29",
            "Downstream Signaling Events Of B Cell Receptor (BCR)53 Show member pathways Signaling by the B Cell Receptor (BCR)53 Activation of RAS in B Cells53",
            "Alzheimers Disease Pathway51",
            "Ca-dependent events53 Show member pathways Neurophysiological process PGE2 induced pain processing58 PLC-gamma1 signalling53 Development Beta adrenergic receptors signaling via cAMP58 Cam-PDE 1 activation53 Inhibitory action of Lipoxin A4 on PDGF, EGF and LTD4 signaling58 Opioid Signalling53 CaM pathway53 DAG and IP3 signaling53 PLC beta mediated events53 Signal transduction Calcium signaling58 G-protein mediated events53 PLCG1 events in ERBB2 signaling53 Beta 2 adrenergic dependent CFTR expression58 Phospholipase C-mediated cascade53 CREB phosphorylation through the activation of Adenylate Cyclase53 PKA-mediated phosphorylation of CREB53 PKA activation in glucagon signalling53 Development Role of Activin A in cell differentiation and proliferation58 PKA activation53 EGFR interacts with phospholipase C-gamma53 Calmodulin induced events53"
        ],
        [
            "Score",
            "9.3",
            "9.3",
            "9.3",
            "9.3",
            "9.3",
            "9.3",
            "9.3",
            "9.3",
            "9.3",
            "9.3",
            "9.3",
            "9.3",
            "9.3",
            "9.3",
            "9.3",
            "9.3",
            "9.3",
            "9.3",
            "9.3",
            "9.3",
            "9.3",
            "9.3",
            "9.3",
            "9.3",
            "9.3",
            "9.3",
            "9.3",
            "9.3"
        ],
        [
            "Top Affiliating Genes",
            "FGFR3, FGFR2",
            "FGFR3, FGFR2",
            "FGFR3, FGFR2",
            "FGFR3, FGFR2",
            "FGFR3, FGFR2",
            "FGFR3, FGFR2",
            "FGFR3, FGFR2",
            "FGFR3, FGFR2",
            "FGFR3, FGFR2",
            "FGFR3, FGFR2",
            "FGFR3, FGFR2",
            "FGFR2, FGFR3",
            "FGFR2, FGFR3",
            "FGFR2, FGFR3",
            "FGFR2, FGFR3",
            "FGFR2, FGFR3",
            "FGFR2, FGFR3",
            "FGFR2, FGFR3",
            "FGFR2, FGFR3",
            "FGFR2, FGFR3",
            "FGFR2, FGFR3",
            "FGFR2, FGFR3",
            "FGFR2, FGFR3",
            "FGFR2, FGFR3",
            "FGFR2, FGFR3",
            "FGFR2, FGFR3",
            "FGFR2, FGFR3",
            "FGFR2, FGFR3"
        ]
    ],
    "pageTitle": "Beare-Stevenson Cutis Gyrata Syndrome disease: Malacards - Research Articles, Symptoms, Drugs, Genes, Clinical Trials",
    "title": "",
    "url": "http://www.malacards.org/card/beare_stevenson_cutis_gyrata_syndrome",
    "hasHeader": true,
    "headerPosition": "FIRST_ROW",
    "tableType": "RELATION",
    "tableNum": 25,
    "s3Link": "common-crawl/crawl-data/CC-MAIN-2015-32/segments/1438042988311.72/warc/CC-MAIN-20150728002308-00073-ip-10-236-191-2.ec2.internal.warc.gz",
    "recordEndOffset": 573214259,
    "recordOffset": 573189858,
    "tableOrientation": "HORIZONTAL",
    "textBeforeTable": "(show all 28) Pathways related to Beare-Stevenson Cutis Gyrata Syndrome according to GeneCards Suite gene sharing: See all sources Thomson Reuters 58 SinoBiological, 54 R&D Systems, 52 Tocris Bioscience, 59 PharmGKB, 49 Reactome, 53 Cell Signaling Technology, 4 NCBI BioSystems Database, 36 KEGG, 29 QIAGEN, 51 PathCards, 48 Sources: Pathways for genes affiliated with Beare-Stevenson Cutis Gyrata Syndrome Jump to section Aliases & Classifications Anatomical Context Animal Models Compounds Drugs & Therapeutics Expression Genes Genetic Tests GO Terms Pathways Products Publications Related Diseases Sources Summaries Symptoms Variations Top Bottom GEO for disease gene expression data for Beare-Stevenson Cutis Gyrata Syndrome. Search See all sources Gene Expression Omnibus",
    "textAfterTable": "Jump to section Aliases & Classifications Anatomical Context Animal Models Compounds Drugs & Therapeutics Expression Genes Genetic Tests GO Terms Pathways Products Publications Related Diseases Sources Summaries Symptoms Variations Top Bottom Compounds for genes affiliated with Beare-Stevenson Cutis Gyrata Syndrome Sources: 59 Tocris Bioscience, 43Novoseek, 12 DrugBank, 49 PharmGKB, 24 HMDB See all sources Compounds related to Beare-Stevenson Cutis Gyrata Syndrome according to GeneCards Suite gene sharing: (show all 14) id Compound Score Top Affiliating Genes 1 su 540259 9.6 FGFR3, FGFR2 2 fiin 1 hydrochloride59 9.6 FGFR3, FGFR2 3 pd 16157059 9.6",
    "hasKeyColumn": false,
    "keyColumnIndex": -1,
    "headerRowIndex": 0
}